Towards a therapeutic use of selective CB2 cannabinoid receptor ligands for atherosclerosis

Author： Steffens Sabine   Mach François  

Publisher： Future Medicine

ISSN： 1479-6678

Source： Future Cardiology, Vol.2, Iss.1, 2006-01, pp. : 49-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TP Receptor as a Therapeutic Target in Atherosclerosis and Related Cardiovascular Diseases

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 1, Iss. 3, 2006-11 ,pp. : 241-247

Bentham Science Publishers

Access to resources Recommend Favorite

Adenosine receptors and cardiovascular disease: The adenosine-1 receptor (A1) and A1 selective ligands

By Hayes E.  

Cardiovascular Toxicology, Vol. 3, Iss. 1, 2003-03 ,pp. : 71-88

Humana Press, Inc

Access to resources Recommend Favorite

Modulation of Strain-Specific Differences in Gene Expression by Cannabinoid Type 2 Receptor Deficiency

By Sophocleous Antonia   Sims Andrew   Idris Aymen   Ralston Stuart  

Calcified Tissue International, Vol. 94, Iss. 4, 2014-04 ,pp. : 423-432

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic Potential for Thyroid Hormone Receptor-&bgr; Selective Agonists for Treating Obesity, Hyperlipidemia and Diabetes

By  

Current Vascular Pharmacology, Vol. 5, Iss. 2, 2007-04 ,pp. : 141-154

Bentham Science Publishers

Access to resources Recommend Favorite

The P2Y12 receptor as a therapeutic target in cardiovascular disease

By Storey R. F.  

Platelets, Vol. 12, Iss. 4, 2001-06 ,pp. : 197-209

Informa Healthcare

Access to resources Recommend Favorite